Having beaten analysts' expectations in each of the last five quarters, Boston Scientific (BSX) will announce on Thursday whether the streak is alive or snapped.

Expectations

Analysts currently expect Boston Scientific to come in with earnings of 11 cents per share on revenues of $1.89 billion. Analyst estimates range from earnings per share to earnings per share. Over the past three months, the average estimate has moved up from 10 cents.

Stock Movement

The stock price has not been doing very well lately. It fell 71 cents per share between May 10, 2012 and June 5, 2012 to close at $5.57. Looking at change over the last three months, April 25, 2012 and July 20, 2012, the stock price fell 77 cents (-12.5%), from $6.15 to $5.38.

Company Fundamental Trends

The company is hoping to use this earnings announcement to snap a string of three-straight quarters of revenue declines. Before falling in the first quarter, revenue had slipped 2.2% in the third quarter of the last fiscal year and 7.7% in fourth quarter of the last fiscal year. The company broke a string of earnings losses last quarter, so the upcoming earnings announcement is a chance to build on recent success. Profit rose in the first quarter after net income declines during the third quarter of the last fiscal year and fourth quarter of the last fiscal year. Stock Ratings

Analysts think investors should stand pat on Boston Scientific with 15 of 22 analysts rating it hold. Analyst sentiment has been waning recently, as the average rating has dropped slightly over the past three months.

Last Quarter's Results

In the first quarter, profit rose more than twofold to $113 million (8 cents a share) from $46 million (3 cents a share) the year earlier, exceeding analyst expectations. Revenue fell 3.1% to $1.87 billion from $1.93 billion.

Summary

Reporting Period: 2Q

Date of Release: Thursday, July 26, 2012 before market open

EPS: 11 cents

Revenue Estimate: $1.89 billion

(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)